MedPath

Determining Developmental and Clinical Markers Affecting Urinary Function of Children With Spinal Dysraphism

Recruiting
Conditions
Spinal Dysraphism
Registration Number
NCT05962086
Lead Sponsor
Seoul National University Hospital
Brief Summary

To identify developmental and clinical biomarkers that affect urinary incontinence at the ages of 5, 7, and 10 according to different neuro-urological clinical factors.

Detailed Description

This retrospective observational cohort study aims to identify developmental and clinical biomarkers that affect urinary incontinence at the ages of 5, 7, and 10 according to the types of spinal dysraphism, conus medullaris location, and urodynamics test results.

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
1500
Inclusion Criteria
  • Those who received spinal dysraphism diagnosis (ICD Code: Q05.1-05.9) and have been following up and receiving treatments due to neurogenic bladder.
Exclusion Criteria
  • As the study is a retrospective study, there is no exclusion criteria.

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Achieving full continence at age 5Age 5

Achieving full urinary and fecal continence at age 5

Achieving full continence at age 7Age 7

Achieving full urinary and fecal continence at age 7.

Achieving full continence at age 10Age 10

Achieving full urinary and fecal continence at age 10

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (6)

Pusan National University Yangsan Hospital

🇰🇷

Yangsan, Gyeongsangnam-do, Korea, Republic of

Asan Medical Center

🇰🇷

Seoul, Korea, Republic of

Keimyung University Dongsan Medical Center

🇰🇷

Daegu, Korea, Republic of

Samsung Medical Center

🇰🇷

Seoul, Korea, Republic of

Seoul National University Hospital

🇰🇷

Seoul, Korea, Republic of

Yonsei University Severance Hospital

🇰🇷

Seoul, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath